Seth Bilazarian MD, FACC, FAHA, FSCAI

Seth Bilazarian, MD was a Clinical and Interventional Cardiologist at Pentucket Medical Associates in Massachusetts from 1993 - 2015. He is board certified in Cardiovascular Medicine, Nuclear Cardiology, Vascular Ultrasound, Interventional Cardiology, and Vascular and Endovascular Medicine. Dr. Bilazarian performed coronary and peripheral interventions at Lahey Clinic and Massachusetts General and directed the Cardiac Cath Lab at Lawrence General. He previously was an Investigator in the cath lab for new devices including DES, imaging devices (OCT, InfraRed, OFDI), and anticoagulants. Dr. Bilazarian was a founder and head of the largest cardiovascular research site in the Partners Healthcare system and an active participant in clinical trials in congestive heart failure, hypertension, CAD prevention, pre-diabetes management, anemia, atrial fibrillation, and anticoagulation and anti-platelet therapies in the outpatient setting. In 2008, he was appointed as a Physician Advisor to the Cardiac Device Panel of the FDA. He joined Abiomed in 2015 and serves as Chief Medical Officer.